Advantis logo

Advantis(OTC) ADVT

Market Cap$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year-99%
1 Year+0%
1 Month-99%
$0.00
+0.00%
+0.00Today
Advantis last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-06
Advantis stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-09
1 month-99%USD 0.002026-09-04
3 month+0%USD 0.002026-07-08
Year to date+0%USD 0.002025-12-23
1 year+0%USD 0.002025-09-24
3 year-99%USD 0.002023-10-04
5 year-99%USD 0.002021-10-07
Since inception-100%USD 1.051996-07-19

Advantis Financials at a Glance

Market Cap

$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-2.10 (Low)

Price

$0.00

Volume

5,999

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

ADVT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Advantis

Advantis Corp. is a company focused on developing and marketing products in the medical cannabis, research, and pharmaceutical sectors. Based in Newport Beach, California, Advantis Corp. aims to provide innovative pain management and healthcare solutions.

Products and Services
  • Medical cannabis products for pain management
  • Healthcare solutions targeting various medical conditions
  • Research initiatives in the pharmaceutical sector
Growth Outlook
  • Recent quarterly revenue showed a significant increase compared to previous periods
  • Expansion into new markets is anticipated to drive future growth
  • Strategic partnerships are being explored to enhance product offerings
Financial Highlights
  • Trailing twelve months (TTM) revenue of $20,474
  • Net income for the latest quarter was -$434,741
  • Current ratio stands at 0.49, indicating liquidity challenges
Advantis Corp. operates in a rapidly evolving industry, with a focus on medical cannabis and healthcare solutions. The company has made strides in product development, aiming to meet the growing demand for effective pain management options. Recent financial data indicates a revenue of $20,474 for the trailing twelve months, reflecting the company's efforts to establish a foothold in the market. However, the net income for the latest quarter was -$434,741, highlighting ongoing challenges in achieving profitability. The current ratio of 0.49 suggests potential liquidity issues, which may impact the company's ability to meet short-term obligations. Despite these challenges, Advantis Corp. is exploring strategic partnerships and market expansion opportunities, which could enhance its growth trajectory. Investors may find the company's focus on innovative healthcare solutions and its commitment to research in the pharmaceutical sector noteworthy as it navigates the complexities of the medical cannabis industry.
AI Generated • Sep 22, 2026

Industry

Pharmaceuticals

Headquarters

Newport Beach, CA 92660, US

ADVT Financials

Key Financial Metrics (TTM)

Gross Margin

92.26%

Operating Margin

-2.78%

Net Income Margin

-2.86%

Return on Equity

1.85%

Return on Capital

N/A

Return on Assets

-4.35%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

878.47M

Volume

6.00K

Avg. Volume

3.08K

Financials (TTM)

Gross Profit

-$65.09K

Operating Income

$3.80M

EBITDA

-$402.00K

Operating Cash Flow

-$517.39K

Capital Expenditure

-$164.33K

Free Cash Flow

-$681.72K

Cash & ST Invst.

$130.04K

Total Debt

$363.32K

Advantis Performance Analysis

Advantis sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12000-03-31N/A
Q32000-09-30-100.0%
Advantis sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12000-03-31N/A
Q32000-09-30-45.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2000YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$57.66K

N/A

Gross Margin

0.00%

N/A

Market Cap

$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$180.00

N/A

Employees

5

N/A

Net Income

-$4.34M

N/A

EBITDA

-$71.30K

N/A

Quarterly Fundamentals

Name
Q3 2000YOY CHG

Total Cash

$130.04K

N/A

Total Debt

$363.32K

N/A

Accounts Receivable

$496.52K

N/A

Inventory

$804.73K

N/A

Long Term Debt

$363.32K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.35%

N/A

Return on Invested Capital

4.00%

N/A

Free Cash Flow

-$681.72K

N/A

Operating Cash Flow

-$517.39K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EAPHParallel Industries Inc.
$0.00+0.00%
NVOSNovo Integrated Sciences, Inc.
$0.00-15.15%
OMHEOMNI Health, Inc.
$0.00+0.00%
CANLCannLabs, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.58-0.51%
INTCIntel
$113.12+0.55%
NVDANvidia
$237.47-0.74%
BULLWebull
$5.89-19.09%

Questions About ADVT

What is the current price of Advantis?

Advantis is trading at $0.00 per share.

What is the 52-week range for Advantis?

Over the past 52 weeks, Advantis has traded between $0.00 and $0.00.

How much debt does Advantis have?

Advantis total debt is unavailable.

How much cash does Advantis have on hand?

Advantis does not have cash on hand data available.

What is Advantis’s dividend yield?

Advantis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.